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Background
Left ventricular ejection fraction (LVEF) is the primary
risk stratification tool used for therapeutic decision
making related to device therapy. However, an influence
of right ventricular dysfunction on cardiovascular events
is becoming apparent. The incremental prognostic value
of right ventricular ejection fraction (RVEF) on future
arrhythmic events among those being considered for
device therapy has not been well examined. In this
study we evaluate the significance of MRI-based mea-
surement of RVEF versus other clinical and MRI-based
variables for their ability to predict Sudden Cardiac
Death (SCD) or Appropriate ICD therapy.
Methods
Consecutive patients with cardiomyopathy were evaluated
for device candidacy. All patients underwent a standard
Late Gadolinium Enhancement (LGE) MRI protocol
followed by a blinded core-laboratory based quantification
of left ventricle (LV) and right ventricle (RV) volumes,
ejection fraction (EF) and total hyperenhancement (HE).
Patients were stratified according to the presence or
absence of significant RV systolic dysfunction, defined as
an RVEF ≤45%. All patients were followed for the occur-
rence of SCD or appropriate ICD therapy. The secondary
outcome was heart failure admission or non-sudden
cardiac death. All clinical and MRI-based variables were
evaluated for associations with the primary and secondary
outcomes with Cox proportional multivariable regression
analysis also performed.
Results
A total of 318 patients (149 ischemic, 169 non-ischemic)
were followed over a median of 467 days. At the end of
follow-up 49 patients (15.4%) suffered a primary outcome
(10 SCD and 39 appropriate therapies). Baseline clinical
characteristics were similar among those with and without
the primary outcome with the exception of prior history
of ventricular arrhythmia and ischemic etiology (p < 0.05).
Following adjustment for etiology, LVEF, LVEDV, and
Total HE, those with an RVEF≤45% were more likely
to experience the primary outcome (HR 2.2; 95% 1.23
to 3.79, p value = 0.007) and the secondary outcome (HR
2.91; 95% CI 1.68 to 5.06, p value = 0.00015) of interest.
Conclusions
Patients with right ventricular dysfunction, defined as
RVEF≤45% by cardiac MRI, are at an increased risk of
future arrhythmic events. Similarly, these individuals are
at an elevated risk of heart failure admission and
non-sudden cardiac death.
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Figure 1 Kaplan-Meier curves showing the separation between
the RVEF > 45% group versus the RVEF < 45% group in event
free days survival for the primary outcome.
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